YAZ, Yasmin, and Ocella Information
What are YAZ, Yasmin, and Ocella?
YAZ and Yasmin are birth control pills, or oral contraceptives, currently manufactured by Bayer HealthCare Pharmaceuticals, Inc. Yasmin was originally made by Berlex Laboratories, which was acquired by Bayer in 2006.
Ocella is the generic equivalent of Yasmin. The Ocella pill is currently manufactured by Teva Pharmaceuticals. Ocella was originally made by Barr Laboratories, which was acquired by Teva in 2008.
Each of these birth control pills contain ethinyl estradiol and the new "fourth generation" progestin drospirenone (DRSP). Drospirenone is already well-known for increasing the risk for hyperkalemia. However, these DRSP oral contraceptives have also been associated with adverse side effects such as:
- Blood Clots
- Deep Vein Thrombosis (DVT)
- Pulmonary Embolism (PE)
- Stroke
- Cerebrovascular Accidents (CVA)
- Heart Attack
- Myocardial Infarction
- Gallbladder Disease / Injury
- Gallbladder Removal (cholecystectomy)
- Kidney Failure or Renal Failure
- Pancreatitis
- Death
Ocella, Yasmin, And YAZ Can Cause Pulmonary Embolism, Deep Vein Thrombosis, Stroke, And Heart Attack
Recent medical journal articles are linking Ocella, Yasmin, and YAZ to pulmonary embolism (PE) and deep vein thrombosis (DVT). These birth control pills each contain drospirenone (DRSP), a unique progestin which causes an increased risk of thromboembolism, or blood clot, side effects when compared to older oral contraceptives (OCs). Estrogen and DRSP create a potentially life-threatening combination due to their coagulative effects.
Yasmin And YAZ MDL (Multidistrict Litigation) Assigned To Judge David R. Herndon, Southern District of Illinois
On October 1, 2009 the United States Judicial Panel on Multidistrict Litigation (JPML) issued a Transfer Order which creates MDL No. 2100. This means that all YAZ and Yasmin personal injury and wrongful death cases filed in the federal court system will be consolidated into a Multidistrict Litigation, or MDL, with U.S. District Court Judge David R. Herndon presiding over these YAZ and Yasmin cases.
In 2009 Bayer Was Required To Correct Advertising Information About Benefits And Risks Of Its YAZ Birth Control Pill
In 2009 Bayer was required to run a $20 million advertising campaign to correct previous YAZ advertisements that overstated the benefits and understated the risks of this popular birth control pill after getting an FDA warning letter. Back in 2003, the FDA sent a similar warning letter about misleading ads for Yasmin.
How And Why YAZ, Yasmin, And Ocella Pills Might Cause A Higher Rate Of Blood Clots In Women
All hormonal birth control options are associated with some health risks. However, the oral contraceptive pills YAZ, Yasmin, and Ocella have the distinction of being associated with a possible higher rate of blood clots. Blood clots from using oral contraceptives like YAZ, Yasmin, and Ocella can cause serious side effects – namely, stroke, heart attack, pulmonary embolism, and deep vein thrombosis. The obvious questions are “How?” and “Why?”.
- Are The Current Warnings About Blood Clot Side Effects Associated With YAZ, Yasmin, and Ocella Sufficient?
- Although the package inserts for YAZ, Yasmin, and Ocella carry a "black box" warning for the increased risk of hyperkalemia associated with these birth control pills, any warnings for the associated blood clot risks are found in only regular print. Now lawsuits are being filed on behalf of women who used these birth control pills alleging there has been a failure to warn about the increased risk of blood clots.
- Birth Control Pill YAZ Being Reviewed For Increased Risk Of Blood Clots And Serious Side Effects
- YAZ is an oral contraceptive, or birth control pill, which combines the new "fourth generation" progestin drospirenone (DRSP) and ethinyl estradiol. YAZ has been associated with several dangerous side effects such as deep vein thrombosis (DVT), pulmonary embolism (PE), heart attacks, and strokes.
- Blood Clot Side Effects Have Long Been A Safety Issue For Yasmin And Its Generic Version, Ocella
- Soon after the Yasmin birth control pill was approved in 2000 there were reports of pulmonary embolism (PE) and deep vein thrombosis (DVT). As a result in 2002 general practitioners in The Netherlands were warned against prescribing Yasmin over the well-known second generation birth control pills.
Oral Contraceptives Such As YAZ, Yasmin, And Ocella Found To Increase The Risk For Gallbladder Disease
- Increasingly, medical studies are finding a clear and formidable link between hormonal contraceptive pills like YAZ, Yasmin, and Ocella and gallbladder complications. These gallbladder injuries often end in gallbladder removal surgery, or
cholecystectomy.
Pulmonary Embolism And Deep Vein Thrombosis: Symptoms, Treatment, and Recovery
For women who are using estrogen-progestin methods of birth control -- such as YAZ, Yasmin, and Ocella -- here is some important information about symptoms, treatment and recovery from a blood clot, which is a serious, potentially fatal side effect of these birth control products.
- YAZ, Yasmin, and Ocella Class Actions
- We believe that people who suffered a serious injury or death due to the YAZ, Yasmin, or Ocella oral contraceptive pills are better served when an individual lawsuit is filed on their behalf. A serious injury or death case should not be filed as part of any YAZ, Yasmin, or Ocella class action together with the claims of many other people who may have had different injuries caused by these birth control pills.
- Legal Compensation for YAZ, Yasmin, and Ocella Injuries
- If you experienced serious side effects from the use of YAZ, Yasmin, or Ocella, or a person died due to an adverse reaction while taking YAZ, Yasmin, or Ocella birth control pills, you may have a claim for legal compensation. Legal compensation claims involving injuries or death caused by the use of YAZ, Yasmin, or Ocella are made by filing a lawsuit in court. All states have statutes of limitations that determine the time period allowed to file a YAZ, Yasmin, or Ocella lawsuit.
- Free YAZ / Yasmin / Ocella Case Evaluation
- The information you provide to us for this Free Case Evaluation will be treated as strictly confidential. You will get a reply from us no later than the next business day. Submitting a case evaluation does not obligate you to hire our law firm for your lawsuit. We handle all cases on a contingency fee basis, which means that you will make no payment for our legal services until after we have succeeded in getting legal compensation for you.
Drug Injury Watch: YAZ / Yasmin / Ocella News And Commentary
|
